Stock Events

Stock Events

Aton 

€0.02
18
+€0.01+155.56% Tuesday 06:05

Statistics

Day High
0.02
Day Low
0.02
52W High
0.02
52W Low
0.01
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 3HB.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
AMGEN
AMGN
Mkt Cap185.74B
Amgen is a biotechnology company that competes in developing innovative therapies, similar to Hybrigenics' focus on cancer and other diseases.
Gilead Sciences
GILD
Mkt Cap161.85B
Gilead Sciences is involved in the research and development of therapeutic products in areas like oncology, competing directly with Hybrigenics' cancer treatment efforts.
Bristol-Myers Squibb
BMY
Mkt Cap119.87B
Bristol-Myers Squibb is a global biopharmaceutical company with a strong emphasis on cancer research and treatments, directly competing with Hybrigenics.
Pfizer
PFE
Mkt Cap153.59B
Pfizer is a global pharmaceutical company with a broad range of products, including in oncology, making it a competitor to Hybrigenics.
Merck
MRK
Mkt Cap276.38B
Merck & Co. focuses on cancer drugs and vaccines, which puts it in direct competition with Hybrigenics in the oncology sector.
Novartis
NVS
Mkt Cap280.79B
Novartis is a global healthcare company that has a significant presence in the oncology market, competing with Hybrigenics.
Roche
RHHBY
Mkt Cap332.61B
Roche Holding AG is a leader in oncology, directly competing with Hybrigenics in the development of cancer treatments.
Astrazeneca
AZN
Mkt Cap294.17B
AstraZeneca is a biopharmaceutical company focusing on the discovery, development, and commercialization of prescription medicines, including for cancer, making it a competitor to Hybrigenics.
Sanofi
SNY
Mkt Cap112.08B
Sanofi is a global healthcare leader that offers treatments in oncology, competing with Hybrigenics in the cancer treatment space.
Lilly(Eli) &
LLY
Mkt Cap789.69B
Eli Lilly and Company is a global pharmaceutical company that has a focus on oncology, competing with Hybrigenics in developing cancer treatments.

About

Hybrigenics SA, together with its subsidiaries, operates as a biotechnology company in France. The company engages in development of biotechnology in the field of biotechnology, oncology, regenerative medicine, and anti-aging medicine. It is also involved in the development of technical solutions using adipose tissue cells and stem cells. The company is headquartered in Gallargues-le-Montueux, France. Hybrigenics SA is a subsidiary of Diagnostic Medical Systems S.A.
Show more...
CEO
ISIN
FR0004153930

Listings

STU
DE
3HB.STU
MU
DE
3HB.MU
F
DE
3HB.F
KQ
KR
158430.KQ

0 Comments

Share your thoughts

FAQ

What is Aton stock price today?▼
The current price of 3HB.MU is €0.02 EUR — it has increased by +155.56% in the past 24 hours. Watch Aton stock price performance more closely on the chart.
What is Aton stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Aton stocks are traded under the ticker 3HB.MU.
Is Aton stock price growing?▼
3HB.MU stock has risen by +196.77% compared to the previous week, the month change is a +196.77% rise, over the last year Aton has showed a +82.18% increase.
In which sector is Aton located?▼
Aton operates in the Other sector.
When did Aton complete a stock split?▼
Aton has not had any recent stock splits.